Cargando…

Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection

INTRODUCTION: Cross‐sectional methods can be used to estimate HIV incidence for surveillance and prevention studies. We evaluated assays and multi‐assay algorithms (MAAs) for incidence estimation in subtype C settings. METHODS: We analysed samples from individuals with subtype C infection with known...

Descripción completa

Detalles Bibliográficos
Autores principales: Laeyendecker, Oliver, Konikoff, Jacob, Morrison, Douglas E, Brookmeyer, Ronald, Wang, Jing, Celum, Connie, Morrison, Charles S, Abdool Karim, Quarraisha, Pettifor, Audrey E, Eshleman, Susan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829581/
https://www.ncbi.nlm.nih.gov/pubmed/29489059
http://dx.doi.org/10.1002/jia2.25082
_version_ 1783302834365661184
author Laeyendecker, Oliver
Konikoff, Jacob
Morrison, Douglas E
Brookmeyer, Ronald
Wang, Jing
Celum, Connie
Morrison, Charles S
Abdool Karim, Quarraisha
Pettifor, Audrey E
Eshleman, Susan H
author_facet Laeyendecker, Oliver
Konikoff, Jacob
Morrison, Douglas E
Brookmeyer, Ronald
Wang, Jing
Celum, Connie
Morrison, Charles S
Abdool Karim, Quarraisha
Pettifor, Audrey E
Eshleman, Susan H
author_sort Laeyendecker, Oliver
collection PubMed
description INTRODUCTION: Cross‐sectional methods can be used to estimate HIV incidence for surveillance and prevention studies. We evaluated assays and multi‐assay algorithms (MAAs) for incidence estimation in subtype C settings. METHODS: We analysed samples from individuals with subtype C infection with known duration of infection (2442 samples from 278 adults; 0.1 to 9.9 years after seroconversion). MAAs included 1‐4 of the following assays: Limiting Antigen Avidity assay (LAg‐Avidity), BioRad‐Avidity assay, CD4 cell count and viral load (VL). We evaluated 23,400 MAAs with different assays and assay cutoffs. We identified the MAA with the largest mean window period, where the upper 95% confidence interval (CI) of the shadow was <1 year. This MAA was compared to the LAg‐Avidity and BioRad‐Avidity assays alone, a widely used LAg algorithm (LAg‐Avidity <1.5 OD‐n + VL >1000 copies/mL), and two MAAs previously optimized for subtype B settings. We compared these cross‐sectional incidence estimates to observed incidence in an independent longitudinal cohort. RESULTS: The optimal MAA was LAg‐Avidity <2.8 OD‐n  +  BioRad‐Avidity <95% + VL >400 copies/mL. This MAA had a mean window period of 248 days (95% CI: 218, 284), a shadow of 306 days (95% CI: 255, 359), and provided the most accurate and precise incidence estimate for the independent cohort. The widely used LAg algorithm had a shorter mean window period (142 days, 95% CI: 118, 167), a longer shadow (410 days, 95% CI; 318, 491), and a less accurate and precise incidence estimate for the independent cohort. CONCLUSIONS: An optimal MAA was identified for cross‐sectional HIV incidence in subtype C settings. The performance of this MAA is superior to a testing algorithm currently used for global HIV surveillance.
format Online
Article
Text
id pubmed-5829581
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58295812018-03-01 Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection Laeyendecker, Oliver Konikoff, Jacob Morrison, Douglas E Brookmeyer, Ronald Wang, Jing Celum, Connie Morrison, Charles S Abdool Karim, Quarraisha Pettifor, Audrey E Eshleman, Susan H J Int AIDS Soc Research Articles INTRODUCTION: Cross‐sectional methods can be used to estimate HIV incidence for surveillance and prevention studies. We evaluated assays and multi‐assay algorithms (MAAs) for incidence estimation in subtype C settings. METHODS: We analysed samples from individuals with subtype C infection with known duration of infection (2442 samples from 278 adults; 0.1 to 9.9 years after seroconversion). MAAs included 1‐4 of the following assays: Limiting Antigen Avidity assay (LAg‐Avidity), BioRad‐Avidity assay, CD4 cell count and viral load (VL). We evaluated 23,400 MAAs with different assays and assay cutoffs. We identified the MAA with the largest mean window period, where the upper 95% confidence interval (CI) of the shadow was <1 year. This MAA was compared to the LAg‐Avidity and BioRad‐Avidity assays alone, a widely used LAg algorithm (LAg‐Avidity <1.5 OD‐n + VL >1000 copies/mL), and two MAAs previously optimized for subtype B settings. We compared these cross‐sectional incidence estimates to observed incidence in an independent longitudinal cohort. RESULTS: The optimal MAA was LAg‐Avidity <2.8 OD‐n  +  BioRad‐Avidity <95% + VL >400 copies/mL. This MAA had a mean window period of 248 days (95% CI: 218, 284), a shadow of 306 days (95% CI: 255, 359), and provided the most accurate and precise incidence estimate for the independent cohort. The widely used LAg algorithm had a shorter mean window period (142 days, 95% CI: 118, 167), a longer shadow (410 days, 95% CI; 318, 491), and a less accurate and precise incidence estimate for the independent cohort. CONCLUSIONS: An optimal MAA was identified for cross‐sectional HIV incidence in subtype C settings. The performance of this MAA is superior to a testing algorithm currently used for global HIV surveillance. John Wiley and Sons Inc. 2018-02-28 /pmc/articles/PMC5829581/ /pubmed/29489059 http://dx.doi.org/10.1002/jia2.25082 Text en © 2018 The Authors. Journal of the International AIDS Society published by John Wiley & sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Laeyendecker, Oliver
Konikoff, Jacob
Morrison, Douglas E
Brookmeyer, Ronald
Wang, Jing
Celum, Connie
Morrison, Charles S
Abdool Karim, Quarraisha
Pettifor, Audrey E
Eshleman, Susan H
Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
title Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
title_full Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
title_fullStr Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
title_full_unstemmed Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
title_short Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
title_sort identification and validation of a multi‐assay algorithm for cross‐sectional hiv incidence estimation in populations with subtype c infection
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829581/
https://www.ncbi.nlm.nih.gov/pubmed/29489059
http://dx.doi.org/10.1002/jia2.25082
work_keys_str_mv AT laeyendeckeroliver identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT konikoffjacob identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT morrisondouglase identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT brookmeyerronald identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT wangjing identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT celumconnie identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT morrisoncharless identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT abdoolkarimquarraisha identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT pettiforaudreye identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection
AT eshlemansusanh identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection